Asahi Kasei Bioprocess Revenue and Competitors

Glenview, IL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Asahi Kasei Bioprocess's estimated annual revenue is currently $45.3M per year.(i)
  • Asahi Kasei Bioprocess's estimated revenue per employee is $155,000

Employee Data

  • Asahi Kasei Bioprocess has 292 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M18-14%N/AN/A
#2
$0.8M50%N/AN/A
#3
$2M130%N/AN/A
#4
$707.3M285214%$1.1BN/A
#5
$1.7M110%N/AN/A
#6
$32.6M2106%N/AN/A
#7
$2.6M176%N/AN/A
#8
$1.1M7-30%N/AN/A
#9
$1.4M9-10%N/AN/A
#10
$2M138%N/AN/A
Add Company

Asahi Kasei Bioprocess provides consumables, equipment, and customized systems for downstream processing of biological and plasma-derived products. Backed by an innate proficiency in applied science & technology and the rich history of Planovaâ„¢ virus-removal filters, our robust approach is defined by quality, consistency, and scalability.

keywords:N/A

N/A

Total Funding

292

Number of Employees

$45.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Asahi Kasei Bioprocess's People

NameTitleEmail/Phone
1
Accounting AssociateReveal Email/Phone
2
Senior Marketing DesignerReveal Email/Phone
3
Quality Control SupervisorReveal Email/Phone
4
Sr. Project EngineerReveal Email/Phone
5
Product ManagerReveal Email/Phone
6
ScientistReveal Email/Phone
7
Sales Manager - The AmericasReveal Email/Phone
8
Automation ManagerReveal Email/Phone
9
Technical WriterReveal Email/Phone
10
Engineering ManagerReveal Email/Phone

Asahi Kasei Bioprocess News

2022-04-17 - Asahi Kasei enters CDMO biz with Bionova buy - BioProcess ...

Through the acquisition of Bionova Scientific, the US arm of Asahi Kasei Medical will add a full-service biologics CDMO to its arsenal.

2022-04-17 - Asahi Kasei enters biologics CDMO business in US deal

Asahi Kasei Medical, through the deal, adds a biopharmaceutical contract development and manufacturing organization (CDMO) to its bioprocess...

2022-04-17 - Asahi Kasei To Acquire Bionova Scientific

Biologics CDMO will complement Asahi Kasei's bioprocess consumables and equipment and biosafety testing services business. Asahi Kasei to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M2964%N/A
#2
$85M3097%N/A
#3
$80.3M357-2%N/A
#4
$70.7M404N/AN/A
#5
$118.1M5255%N/A

Asahi Kasei Bioprocess Executives


NameTitle
Chris NordhoffPresident (2016-Present) & Managing Director, Asahi Kasei Bioprocess Deutschland GmbH (2012-Present)
Parag PatelVice President Of Business Development
Chris RombachVP of Sales and Marketing
Naokatsu HirotomiExecutive Vice President and General Manager
Brian CrawfordVP, Operations
Taka SohkaVice President Science & Technology
Chris NordhoffPresident (2016-Present) & Managing Director, Asahi Kasei Bioprocess Deutschland GmbH (2012-Present)